Publisher Correction: Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial

Affiliations

¹ National Cancer Institute, Center for Cancer Research, Surgery Branch, Bethesda, MD, USA.
² National Cancer Institute, Center for Cancer Research, Surgery Branch, Bethesda, MD, USA. stephanie.goff@nih.gov.
³ National Cancer Institute, Center for Cancer Research, Thoracic Surgery Branch, Bethesda, MD, USA.
⁴ National Cancer Institute, Center for Cancer Research, Surgical Oncology Program, Bethesda, MD, USA.
⁵ National Cancer Institute, Center for Cancer Research, Surgery Branch, Bethesda, MD, USA. sar@nih.gov.

^# Contributed equally.

Published Erratum

Frank J Lowery et al. Nat Med. 2025 Jun.

. 2025 Jun;31(6):2072.

doi: 10.1038/s41591-025-03708-5.

¹ National Cancer Institute, Center for Cancer Research, Surgery Branch, Bethesda, MD, USA.
² National Cancer Institute, Center for Cancer Research, Surgery Branch, Bethesda, MD, USA. stephanie.goff@nih.gov.
³ National Cancer Institute, Center for Cancer Research, Thoracic Surgery Branch, Bethesda, MD, USA.
⁴ National Cancer Institute, Center for Cancer Research, Surgical Oncology Program, Bethesda, MD, USA.
⁵ National Cancer Institute, Center for Cancer Research, Surgery Branch, Bethesda, MD, USA. sar@nih.gov.

^# Contributed equally.

No abstract available

Erratum for

Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial.
Lowery FJ, Goff SL, Gasmi B, Parkhurst MR, Ratnam NM, Halas HK, Shelton TE, Langhan MM, Bhasin A, Dinerman AJ, Dulemba V, Goldlust IS, Gustafson AM, Hakim AA, Hitscherich KJ, Kenney LM, Levy L, Rault-Wang JG, Bera A, Ray S, Seavey CD, Hoang CD, Hernandez JM, Gartner JJ, Sindiri S, Prickett TD, McIntyre LS, Krishna S, Robbins PF, Klemen ND, Kwong MLM, Yang JC, Rosenberg SA. Lowery FJ, et al. Nat Med. 2025 Jun;31(6):1994-2003. doi: 10.1038/s41591-025-03627-5. Epub 2025 Apr 1. Nat Med. 2025. PMID: 40169866 Free PMC article. Clinical Trial.